CT
DNA icon

Cambridge Trust’s Ginkgo Bioworks DNA Stock Holding History

Cambridge Trust’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$232 Hold
5
– – ﹤0.01% 648
2023
Q4 		$338 Hold
5
– – ﹤0.01% 677
2023
Q3 		$362 Hold
5
– – ﹤0.01% 700
2023
Q2 		$372 Buy
+5
New +$296 ﹤0.01% 684

Other funds holding DNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cambridge Trust's DNA Position: Q1 2024 in Review

Cambridge Trust held its Ginkgo Bioworks (DNA) position steady in Q1 2024 at 5 shares worth $232. The position accounts for ﹤0.01% of the portfolio, ranked #648.

Cambridge Trust first reported a position in DNA in Q2 2023 and has held it in 4 quarters since. The position peaked at $372 in Q2 2023. 342 funds tracked by Wall St. Rank hold DNA as of Q1 2024.

  • Cambridge Trust held 5 shares of Ginkgo Bioworks worth $232 as of Q1 2024.
  • Cambridge Trust left its Ginkgo Bioworks share count unchanged in Q1 2024.
  • Ginkgo Bioworks made up ﹤0.01% of Cambridge Trust's portfolio in Q1 2024, its #648 holding.
  • Cambridge Trust first reported a position in Ginkgo Bioworks in Q2 2023 and has held it in 4 quarters since.
  • Cambridge Trust's Ginkgo Bioworks position peaked at $372 in Q2 2023.
  • 342 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2024.

Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.